ICICIGI.NSE News

New Delhi [India], May 2: ICICI Lombard presents Get Some Sun returns for Season 9 with a brand new theme, fresh stories, and the charismatic Ayushmann Khurana leading the journey once again. Actor, singer, storyteller, and passionate traveller, Ayushmann is set to take listeners on unforgettable adventures that go beyond destinations and straight into the heart of travel.

In this briefing: IDFC First Bank Ltd - Steady Recovery Underway; Operating Leverage to Drive RoA Improvement ICICI Life (IPRU IN) Vs ICICI GIC (ICICIGI IN): Life Vs General Insurance Spread Signals Trade US Semiconductor China Export Restrictions. Game, Set & Now Let's Try MATCH! Exencial Industry Tidings - 27-04-2026 APAC Healthcare Weekly (April 26) – Sino Bio, Wuxi Bio, Astellas Pharma, Eisai, Celltrion, Cochlear 1. IDFC First Bank Ltd - Steady Recovery Underway; Operating Leverage to Drive RoA Improvement Deposit Growth Temporarily Impacted; Recovery Underway: In Q4, IDFCFB’s deposit growth was flat QoQ, impacted by a combination of SA rate rationalisation, tight systemic liquidity, seasonal outflows, and a one-off incident at the Haryana branch. Encouragingly, early trends in Apr’26 indicate a revival in deposit accretion momentum, supported by sustained customer acquisition, thereby suggesting a return to normalised growth in the near term. Management remains confident of returning to ~5% QoQ growth from Q1 onwards.

In this briefing: ICICI Life (IPRU IN) Vs ICICI GIC (ICICIGI IN): Life Vs General Insurance Spread Signals Trade US Semiconductor China Export Restrictions. Game, Set & Now Let's Try MATCH! Exencial Industry Tidings - 27-04-2026 APAC Healthcare Weekly (April 26) – Sino Bio, Wuxi Bio, Astellas Pharma, Eisai, Celltrion, Cochlear HDFC Bank (HDFCB IN) Vs. Yes Bank (YES IN): Large–Small Bank Spread Signals Statistical Arbitrage 1. ICICI Life (IPRU IN) Vs ICICI GIC (ICICIGI IN): Life Vs General Insurance Spread Signals Trade Context: The ICICI Lombard General Insurance (ICICIGI IN) vs. ICICI Prudential Life (IPRU IN) price-ratio has deviated two standard deviations from its one-year average, presenting a potential relative value opportunity. Highlight: Going long ICICI Prudential Life Insurance (IPRU IN) and short ICICI Lombard General Insurance Company (ICICIGI IN) targets a 6% return. Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play. 2.

In this briefing: The Token Maxxing Delusion Yasho Industries Ltd- Chemistry Without Cash Primer: Info Edge India (INFOE IN) - Apr 2026 Primer: Bajaj Housing Finance (BHF IN) - Apr 2026 Primer: ICICI Lombard General Insurance Company (ICICIGI IN) - Apr 2026 1. The Token Maxxing Delusion Earlier this month, Fortune reported that Meta’s 85,000 employees were competing on an internal AI leaderboard called “Claudeonomics”. Welcome to the world of Token Maxxing . Now that the door is closing on Agentic AI being able to sneak in under the cover of a monthly subscription, Token Optimisation should become front & center for every enterprise Treat your agentic sessions like sprints. Define a clear objective for each session. Work to completion or a meaningful checkpoint. Then summarise and reset. You will save a fortune... 2. Yasho Industries Ltd- Chemistry Without Cash Yasho Industries (YASHO IN) operating cash flows are materially misstated due to misclassifications. Cash conversion is weak in the long run.

Broader markets outperformed, with midcaps and smallcaps gaining up to 1%. Strong earnings from Persistent and ICICI Lombard further fueled sentiment.

The analyst said ICICI Lombard’s focus on disciplined underwriting, cost control, and stronger capital efficiency is driving sustainable profitability.

Analysts see Nifty facing resistance near 25,300, with key support at 25,000.

Axis Bank, HDFC Life Insurance, HDFC AMC, and L&T Finance are among the companies reporting their Q2 print today

The GST Council exempted life and health policies from tax. Analysts say traditional insurers and standalone health players stand to gain most.